Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis

被引：62

作者：

Euba, G. ^{[1
]}

Murillo, O. ^{[1
]}

Fernandez-Sabe, N. ^{[1
]}

Mascaro, J. ^{[1
]}

Cabo, J. ^{[2
]}

Perez, A. ^{[2
]}

Tubau, F. ^{[3
]}

Verdaguer, R. ^{[3
]}

Gudiol, F. ^{[1
]}

Ariza, J. ^{[1
]}

机构：

[1] Hosp Univ Bellvitge, Dept Infect Dis, IDIBELL, Barcelona 08907, Spain

[2] Hosp Univ Bellvitge, Dept Orthoped Surg, IDIBELL, Barcelona 08907, Spain

[3] Hosp Univ Bellvitge, Dept Microbiol, IDIBELL, Barcelona 08907, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 06期

关键词：

INFECTED ORTHOPEDIC IMPLANTS; TRIMETHOPRIM-SULFAMETHOXAZOLE; AUREUS; OFLOXACIN; INVIVO; ANTIBIOTICS; INVITRO; VANCOMYCIN; EFFICACY; AGENTS;

D O I：

10.1128/AAC.01504-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Oral therapies alternative to fluoroquinolones against staphylococcal chronic osteomyelitis have not been evaluated in comparative studies. Consecutive nonaxial Staphylococcus aureus chronic osteomyelitis cases were included in a comparative trial after debridement. Fifty patients were randomized: group A (n = 22) was treated with cloxacillin for 6 weeks intravenously plus 2 weeks orally (p.o.), and group B (n = 28) was treated with rifampin-cotrimoxazole for 8 weeks p.o. During follow-up (10 years), five relapses occurred: two (10%) in group A and three (11%) in group B. Foreign-body maintenance was associated with relapse (P = 0.016). Oral rifampin-cotrimoxazole treatment showed outcomes comparable to those for intravenous cloxacillin treatment.

引用

页码：2672 / 2676

页数：5

共 26 条

[21] OSTEOMYELITIS - THE PAST DECADE [J].

WALDVOGEL, FA ;

VASEY, H .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (07) :360-370

[22]

WIDMER A, 1988, SCHWEIZ MED WSCHR, V118, P23

[23] CORRELATION BETWEEN INVIVO AND INVITRO EFFICACY OF ANTIMICROBIAL AGENTS AGAINST FOREIGN-BODY INFECTIONS [J].

WIDMER, AF ;

FREI, R ;

RAJACIC, Z ;

ZIMMERLI, W .

JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :96-102

[24] ANTIMICROBIAL TREATMENT OF ORTHOPEDIC IMPLANT-RELATED INFECTIONS WITH RIFAMPIN COMBINATIONS [J].

WIDMER, AF ;

GAECHTER, A ;

OCHSNER, PE ;

ZIMMERLI, W .

CLINICAL INFECTIOUS DISEASES, 1992, 14 (06) :1251-1253

[25] INVITRO AND INVIVO STUDIES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AGAINST MULTIPLE RESISTANT STAPHYLOCOCCUS-AUREUS [J].

YELDANDI, V ;

STRODTMAN, R ;

LENTINO, JR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (06) :873-880

[26] Role of rifampin for treatment of orthopedic implant-related staphylococcal infections - A randomized controlled trial [J].

Zimmerli, W ;

Widmer, AF ;

Blatter, M ;

Frei, R ;

Ochsner, PE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1537-1541

← 1 2 3 →